2-Fluoroanisole | CAS:321-28-8

We serve 2-Fluoroanisole CAS:321-28-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Fluoroanisole

Chemical Name:   2-Fluoroanisole
CAS.NO: 321-28-8
Synonyms:monofluoroanisole;
2-fluoro-anisole;
2-fluoromethoxybenzene;
ortho-fluoroanisole;
2-methoxyfluorobenzene;
Molecular Formula:C7H7FO
Molecular Weight: 126.12800
 
Physical and Chemical Properties:
Density: 1.124 g/mL at 25 °C(lit.)
Melting point: −39 °C(lit.)
Boiling point: 154-155 °C(lit.)
Flash point:140 °F
Index of Refraction:1.494
 
Specification:
Appearance: Colorless Liquid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:   used in thePharmaceutical intermediate



Contact us for information like 2-Fluoroanisole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methoxyfluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ortho-fluoroanisole Use and application,ortho-fluoroanisole technical grade,usp/ep/jp grade.


Related News: In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.2-Anilino-6-dibutylamino-3-methylfluoran manufacturer Slow business: Due to fear — and travel warnings — fewer people want to travel to China.bisphenol AF supplier Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.Catechol vendor Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.